Sarah E. Bond Newton

Sarah E. Bond Newton

Auto-generated profile, based on publicly available information

Sarah E. Bond Newton

Department of Oral Medicine, Penn Dental School, University of Pennsylvania

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2020 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
SBSarah Bond
Sarah Bond
CLClaudia Lopez Lloreda
Claudia Lopez Lloreda
PGPatrick J Gannon
Patrick J Gannon
CACagla Akay-Espinoza
Cagla Akay-Espinoza
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
The proposed molecular mechanisms underlying neurodegenerative pathogenesis are varied, precluding the development of effective therapies for these increasingly prevalent disorders. One of the most consistent observations across neurodegenerative diseases is the phosphorylation of eukaryotic initiation factor 2α (eIF2α). eIF2α is a translation initiation factor, involved in cap-dependent protein translation, which when phosphorylated causes global translation attenuation. eIF2α phosphorylation is mediated by 4 kinases, which, together with their downstream signaling cascades, constitute the integrated stress response (ISR). While the ISR is activated by stresses commonly observed in neurodegeneration, such as oxidative stress, endoplasmic reticulum stress, and inflammation, it is a canonically adaptive signaling cascade. However, chronic activation of the ISR can contribute to neurodegenerative phenotypes such as neuronal death, memory impairments, and protein aggregation via apoptotic induction and other maladaptive outcomes downstream of phospho-eIF2α-mediated translation inhibition, including neuroinflammation and altered amyloidogenic processing, plausibly in a feed-forward manner. This review examines evidence that dysregulated eIF2a phosphorylation acts as a driver of neurodegeneration, including a survey of observations of ISR signaling in human disease, inspection of the overlap between ISR signaling and neurodegenerative phenomenon, and assessment of recent encouraging findings ameliorating neurodegeneration using developing pharmacological agents which target the ISR. In doing so, gaps in the field, including crosstalk of the ISR kinases and consideration of ISR signaling in nonneuronal central nervous system cell types, are highlighted.

17 October 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
APAidan T. Pezacki
Aidan T. Pezacki
CMCarson D. Matier
Carson D. Matier
XGXingxing Gu
Xingxing Gu
EKEric Kummelstedt
Eric Kummelstedt
SBSarah E. Bond
Sarah E. Bond
CCChristopher J. Chang
Christopher J. Chang
Copper is an essential metal nutrient for life that often relies on redox cycling between Cu(I) and Cu(II) oxidation states to fulfill its physiological roles, but alterations in cellular redox status can lead to imbalances in copper homeostasis that contribute to cancer and other metalloplasias with metal-dependent disease vulnerabilities. Copper-responsive fluorescent probes offer powerful tools to study labile copper pools, but most of these reagents target Cu(I), with limited methods for monitoring Cu(II) owing to its potent fluorescence quenching properties. Here, we report an activity-based sensing strategy for turn-on, oxidation state-specific detection of Cu(II) through metal-directed acyl imidazole chemistry. Cu(II) binding to a metal and oxidation state-specific receptor that accommodates the harder Lewis acidity of Cu(II) relative to Cu(I) activates the pendant dye for reaction with proximal biological nucleophiles and concomitant metal ion release, thus avoiding fluorescence quenching. Copper-directed acyl imidazole 649 for Cu(II) (CD649.2) provides foundational information on the existence and regulation of labile Cu(II) pools, including identifying divalent metal transporter 1 (DMT1) as a Cu(II) importer, labile Cu(II) increases in response to oxidative stress induced by depleting total glutathione levels, and reciprocal increases in labile Cu(II) accompanied by decreases in labile Cu(I) induced by oncogenic mutations that promote oxidative stress.

27 September 2025 in Cell Reports
Verified
Journal Article
Open access
SNSarah E. Bond Newton
Sarah E. Bond Newton
XSXinglong Shi
Xinglong Shi
NBNoah R. Beratan
Noah R. Beratan
JPJulia Perhacs
Julia Perhacs
JAJitendra K. Arya
Jitendra K. Arya
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
Pancreatic/PKR-like endoplasmic reticulum (ER) kinase (PERK) is a kinase that, in response to ER stress, mediates dual homeostatic and pro-apoptotic signaling. Thus, intricate regulation is required for physiological function. Attempts to modulate PERK activity have shown that the determinants of adaptive vs. maladaptive signaling remain ambiguous. Here, with purified protein, we provide evidence that PERK binds copper, identifies residues required for interaction, and demonstrates that copper is necessary for kinase activity. Furthermore, cellular PERK activity can be modulated via copper availability, and this regulatory relationship can be manipulated to dictate ER stress tolerance. Critically, these phenomena translate to phenotypes in vivo, as C. elegans harboring a "PERK-copper mutant" exhibit exacerbated ER-stress sensitivity. The copper-PERK paradigm suggests that copper homeostasis, as a regulator of PERK, may constitute a critical factor in resolving the long-standing ambiguity in endeavors to therapeutically target PERK.

23 April 2022 in medRxiv
Verified
Preprint
Open access
PDF file
CACagla Akay-Espinoza
Cagla Akay-Espinoza
SBSarah Bond
Sarah Bond
BDBeth A. Dombroski
Beth A. Dombroski
AMAsha R. MPH
Asha R. MPH
ABAjay Bharti
Ajay Bharti
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
Coding and noncoding single-nucleotide variants (SNVs) of EIF2AK3 , which encodes an integrated stress response (ISR) kinase, may play a role in neurodegenerative disorders. We used a candidate gene approach to determine the correlation of EIF2AK3 SNVs with neurocognitive (NC) impairment (NCI), which can persist with viral suppression from antiretroviral therapy (ART) in people with HIV (PWH). This retrospective study of prospectively collected data included participants of the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) cohort, after excluding participants with severe neuropsychiatric comorbidities. Genome-wide data previously obtained in the CHARTER cohort participants (n=1,047) were analyzed to interrogate the association of three noncoding EIF2AK3 SNVs with the continuous global deficit score (GDS) and global NCI (GDS≥0.5). Targeted sequencing (TS) was performed in 992 participants with available genomic DNA to determine the association of three coding EIF2AK3 SNVs with GDS and NCI. Analyses included univariable and multivariable methods such as analysis of variance and regression. Multivariable models covaried demographic, disease-associated, and treatment characteristics. The cohort characteristics were as follows: median age, 43.1 years; females, 22.8%; European ancestry, 41%; median CD4+ T cell counts, 175/µL (nadir) and 428/µL (current). At first assessment, 70.5% used ART and 68.3% of these had plasma HIV RNA ≤ 200 copies/mL. A minority of participants had at least one risk allele for rs6739095 (T,41.7%), rs1913671 (C,41.4%), and rs11684404 (C,39.4%). All three noncoding EIF2AK3 SNVs were associated with significantly worse GDS and more NCI (all p <0.05). By TS, fewer participants had at least one risk allele for rs1805165 (G,30.9%), rs867529 (G,30.9%), and rs13045 (A,41.2%). Homozygosity for all three coding SNVs was associated with significantly worse GDS and more NCI (all p 13 were independently associated with GDS and NCI ( p <0.001). The other two coding SNVs did not significantly correlate with GDS or NCI after including rs13045 in the model. The coding EIF2AK3 SNVs were specifically associated with worse performance in executive functioning, motor functioning, learning, and verbal fluency. Coding and non-coding SNVs of EIF2AK3 were associated with global NC and domain-specific performance. The effects were small-to-medium in size but were present in multivariable analyses. Specific SNVs in EIF2AK3 may be an important component of genetic vulnerability to NC complications in PWH. Identification of host factors that predict NCI could allow for earlier interventions, including those directly modulating the ISR, to improve NC outcomes.

30 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SGShivesh Ghura
Shivesh Ghura
EAElena Alvarez-Periel
Elena Alvarez-Periel
SNSarah E. Bond Newton
Sarah E. Bond Newton
CACagla Akay-Espinoza
Cagla Akay-Espinoza
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
Subtle variations in the activity and signaling of PERK, an endoplasmic reticulum kinase, can shift stress response outcomes. PERK has three commonly occurring exonic single-nucleotide variants frequently inherited together as part of the PERK haplotype B (PERK-B), which occurs in 28% of the global population and is associated with several chronic neurodegenerative diseases, although its impact on PERK activity remains controversial. We hypothesized that PERK-B was associated with increased activity, altering stress response and stress tolerance, and that minorly but consistently elevated PERK activity, in combination with additional environmental or genetic risk factors, would lead to adverse outcomes. Comparison of stress response between PERK-A, the major PERK haplotype, and PERK-B in neuronal cultures using novel knock-in PERK-B mice alongside wild-type PERK-A mice revealed differential, transient changes. Following ER stress, astrocyte-containing neuronal cultures, but not neuron-only cultures expressing PERK-B exhibited similar levels of eIF2α phosphorylation, the canonical PERK substrate at PERK peak activation point (2h), but showed higher levels at 4–6 h, consistent with altered kinetics of PERK signaling. PERK-B neuronal cultures pretreated with a low-dose PERK-specific activator exhibited increased vulnerability to N-methyl-D-aspartate-induced death compared to PERK-A neuronal cultures, indicating impaired acquired stress tolerance. Additionally, neuron-astrocyte coculture experiments revealed that the observed difference in acquired stress tolerance was dependent on the astrocyte genotype. The association of PERK-B with transient changes in stress response and reduced stress tolerance with higher vulnerability to cellular stress, albeit transient and small/moderate in size, has clinical relevance based on its potential contribution to the overall genetic vulnerability in neurodegenerative diseases.

2 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SNSarah E. Bond Newton
Sarah E. Bond Newton
NBNoah R. Beratan
Noah R. Beratan
CACagla Akay-Espinoza
Cagla Akay-Espinoza
MBMargaret K. Bond
Margaret K. Bond
XSXinglong Shi
Xinglong Shi
KJKelly L. Jordan-Sciutto
Kelly L. Jordan-Sciutto
Summary: PERK is a kinase that, in response to ER stress, mediates duplicitous homeostatic and pro-apoptotic signaling. Thus, intricate regulation is required for physiologic function. Attempts to modulate PERK activity have shown that the determinants of adaptive vs. mal-adaptive signaling remain ambiguous. Here, with purified protein, we provide direct evidence that PERK binds copper, identify the residues that coordinate binding, and demonstrate that binding is necessary for kinase activity. Furthermore cellular PERK activity can be modulated via copper availability, and this regulatory relationship can be manipulated to dictate ER stress tolerance. Critically, these phenomenon translate to phenotypes in vivo , as C. elegans harboring a “copper-binding mutant” of PERK exhibit enhanced ER-stress sensitivity. The copper-PERK paradigm adds onto a new class of dynamic copper-binding enzymes and implicates that copper homeostasis, as a regulator of PERK, may constitute a previously unknown variable to resolve long-standing ambiguity in endeavors to therapeutically target PERK.